Literature DB >> 16300412

Analysis of the specificity of sialyltransferases toward mucin core 2, globo, and related structures. identification of the sialylation sequence and the effects of sulfate, fucose, methyl, and fluoro substituents of the carbohydrate chain in the biosynthesis of selectin and siglec ligands, and novel sialylation by cloned alpha2,3(O)sialyltransferase.

E V Chandrasekaran1, Jun Xue, Jie Xia, Ram Chawda, Conrad Piskorz, Robert D Locke, Sriram Neelamegham, Khushi L Matta.   

Abstract

Sialic acids are key determinants in many carbohydrates involved in biological recognition. We studied the acceptor specificities of three cloned sialyltransferases (STs) [alpha2,3(N)ST, alpha2,3(O)ST, and alpha2,6(N)ST] and another alpha2,3(O)ST present in prostate cancer cell LNCaP toward mucin core 2 tetrasaccharide [Galbeta1,4GlcNAcbeta1,6(Galbeta1,3)GalNAcalpha-O-Bn] and Globo [Galbeta1,3GalNAcbeta1,3Galalpha-O-Me] structures containing sialyl, fucosyl, sulfo, methyl, or fluoro substituents by identifying the products by electrospray ionization tandem mass spectral analysis and other biochemical methods. The Globo precursor was an efficient acceptor for both alpha2,3(N)ST and alpha2,3(O)ST, whereas only alpha2,3(O)ST used its deoxy analogue (d-Fucbeta1,3GalNAcbeta1,3-Gal-alpha-O-Me); 2-O-MeGalbeta1,3GlcNAc and 4-OMeGalbeta1,4GlcNAc were specific acceptors for alpha2,3(N)ST. Other major findings of this study include: (i) alpha2,3 sialylation of beta1,3Gal in mucin core 2 can proceed even after alpha1,3 fucosylation of beta1,6-linked LacNAc. (ii) Sialylation of beta1,3Gal must precede the sialylation of beta1,4Gal for favorable biosynthesis of mucin core 2 compounds. (iii) alpha2,3 sialylation of the 6-O-sulfoLacNAc moiety in mucin core 2 (e.g., GlyCAM-1) is facilitated when beta1,3Gal has already been alpha2,3 sialylated. (iv) alpha2,6(N)ST was absolutely specific for the beta1,4Gal in mucin core 2. Either alpha1,3 fucosylation or 6-O-sulfation of the GlcNAc moiety reduced the activity. Sialylation of beta1,3Gal in addition to 6-O-sulfation of GlcNAc moiety abolished the activity. (v) Prior alpha2,3 sialylation or 3-O-sulfation of beta1,3Gal would not affect alpha2,6 sialylation of Galbeta1,4GlcNAc of mucin core 2. (vi) A 3- or 4-fluoro substituent in beta1,4Gal resulted in poor acceptors for the cloned alpha2,6(N)ST and alpha2,3(N)ST, whereas 4-fluoro- or 4-OMe-Galbeta1,3GalNAcalpha was a good acceptor for cloned alpha2,3(O)ST. (vii) 4-O-Methylation of beta1,4Gal abolished the acceptor ability toward alpha2,6(N)ST but increased the acceptor efficiency considerably toward alpha2,3(N)ST. (viii) Just like LNCaPalpha1,2-FT and Gal-3-O-sulfotransferase T2, the cloned alpha2,3(N)ST which modifies terminal Gal in Galbeta1,4GlcNAc also efficiently utilizes the terminal beta1,3Gal in the Globo backbone. Utilization of C-3 blocked compounds such as 3-O-sulfo-Galbeta1,3GalNAcbeta1,3Galalpha-OMe as acceptors by cloned alpha2,3(O)ST and analyses of the resulting products by lectin chromatography and mass spectrometry indicate that alpha2,3(O)ST is capable of attaching NeuAc to another position in C-3-substituted beta1,3Gal.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16300412     DOI: 10.1021/bi050246m

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  16 in total

1.  A systematic analysis of acceptor specificity and reaction kinetics of five human α(2,3)sialyltransferases: Product inhibition studies illustrate reaction mechanism for ST3Gal-I.

Authors:  Rohitesh Gupta; Khushi L Matta; Sriram Neelamegham
Journal:  Biochem Biophys Res Commun       Date:  2015-12-13       Impact factor: 3.575

2.  Reversible sialylation: synthesis of cytidine 5'-monophospho-N-acetylneuraminic acid from cytidine 5'-monophosphate with alpha2,3-sialyl O-glycan-, glycolipid-, and macromolecule-based donors yields diverse sialylated products.

Authors:  E V Chandrasekaran; Jun Xue; Jie Xia; Robert D Locke; Khushi L Matta; Sriram Neelamegham
Journal:  Biochemistry       Date:  2007-12-08       Impact factor: 3.162

3.  Glycan microarrays for screening sialyltransferase specificities.

Authors:  Ola Blixt; Kirk Allin; Ognian Bohorov; Xiaofei Liu; Hillevi Andersson-Sand; Julia Hoffmann; Nahid Razi
Journal:  Glycoconj J       Date:  2007-10-04       Impact factor: 2.916

4.  Mammalian sialyltransferase ST3Gal-II: its exchange sialylation catalytic properties allow labeling of sialyl residues in mucin-type sialylated glycoproteins and specific gangliosides.

Authors:  E V Chandrasekaran; Jun Xue; Jie Xia; Robert D Locke; Shilpa A Patil; Sriram Neelamegham; Khushi L Matta
Journal:  Biochemistry       Date:  2011-10-13       Impact factor: 3.162

5.  Scaling down the size and increasing the throughput of glycosyltransferase assays: activity changes on stem cell differentiation.

Authors:  Shilpa A Patil; E V Chandrasekaran; Khushi L Matta; Abhirath Parikh; Emmanuel S Tzanakakis; Sriram Neelamegham
Journal:  Anal Biochem       Date:  2012-03-23       Impact factor: 3.365

6.  Overexpression of α2,3sialyl T-antigen in breast cancer determined by miniaturized glycosyltransferase assays and confirmed using tissue microarray immunohistochemical analysis.

Authors:  Shilpa A Patil; Wiam Bshara; Carl Morrison; E V Chandrasekaran; Khushi L Matta; Sriram Neelamegham
Journal:  Glycoconj J       Date:  2014-10       Impact factor: 2.916

7.  Identification and Biochemical Characterization of the Novel α2,3-Sialyltransferase WbwA from Pathogenic Escherichia coli Serotype O104.

Authors:  Diana Czuchry; Paul Desormeaux; Melissa Stuart; Donald L Jarvis; Khushi L Matta; Walter A Szarek; Inka Brockhausen
Journal:  J Bacteriol       Date:  2015-09-21       Impact factor: 3.490

8.  Quantitative serum glycomics of esophageal adenocarcinoma and other esophageal disease onsets.

Authors:  Yehia Mechref; Ahmed Hussein; Slavka Bekesova; Vitara Pungpapong; Min Zhang; Lacey E Dobrolecki; Robert J Hickey; Zane T Hammoud; Milos V Novotny
Journal:  J Proteome Res       Date:  2009-06       Impact factor: 4.466

9.  alpha2,3-sialyltransferase ST3Gal III modulates pancreatic cancer cell motility and adhesion in vitro and enhances its metastatic potential in vivo.

Authors:  Marta Pérez-Garay; Beatriz Arteta; Lluís Pagès; Rafael de Llorens; Carme de Bolòs; Fernando Vidal-Vanaclocha; Rosa Peracaula
Journal:  PLoS One       Date:  2010-09-01       Impact factor: 3.240

10.  Potential tumor markers for human gastric cancer: an elevation of glycan:sulfotransferases and a concomitant loss of alpha1,2-fucosyltransferase activities.

Authors:  E V Chandrasekaran; Jun Xue; Conrad Piskorz; Robert D Locke; Károly Tóth; Harry K Slocum; Khushi L Matta
Journal:  J Cancer Res Clin Oncol       Date:  2007-05-11       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.